Puma Biotechnology, Inc.PBYINASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank79
3Y CAGR+35.6%
5Y CAGR+64.3%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+35.6%/yr
vs +19.1%/yr prior
5Y CAGR
+64.3%/yr
Recent deceleration
Acceleration
+16.5pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
12x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 23.63% |
| Q3 2025 | 5.40% |
| Q2 2025 | 13.21% |
| Q1 2025 | -21.49% |
| Q4 2024 | -12.22% |
| Q3 2024 | 41.24% |
| Q2 2024 | 10.25% |
| Q1 2024 | -30.96% |
| Q4 2023 | 11.73% |
| Q3 2023 | 0.28% |
| Q2 2023 | 7.97% |
| Q1 2023 | -19.01% |
| Q4 2022 | 9.49% |
| Q3 2022 | 0.02% |
| Q2 2022 | 27.82% |
| Q1 2022 | -19.72% |
| Q4 2021 | 20.84% |
| Q3 2021 | -13.16% |
| Q2 2021 | -39.64% |
| Q1 2021 | 64.87% |
| Q4 2020 | 1.97% |
| Q3 2020 | -33.28% |
| Q2 2020 | 45.15% |
| Q1 2020 | -20.16% |
| Q4 2019 | 12.30% |
| Q3 2019 | 5.38% |
| Q2 2019 | -51.04% |
| Q1 2019 | 49.84% |
| Q4 2018 | 13.43% |
| Q3 2018 | 27.81% |
| Q2 2018 | -30.26% |
| Q1 2018 | 243.62% |
| Q4 2017 | 284.53% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |